• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有产生人绒毛膜促性腺激素和糖类抗原19-9的浆细胞样变体的尿路上皮癌。

Urothelial carcinoma with plasmacytoid variants producing both human chorionic gonadotropin and carbohydrate antigen 19-9.

作者信息

Shimada Keiji, Nakamura Mitsutoshi, Ishida Eiwa, Konishi Noboru

机构信息

Department of Pathology, Nara Medical University School of Medicine, Nara, Japan.

出版信息

Urology. 2006 Oct;68(4):891.e7-10. doi: 10.1016/j.urology.2006.05.029.

DOI:10.1016/j.urology.2006.05.029
PMID:17070387
Abstract

Plasmacytoid urothelial carcinoma is a rare malignant neoplasm in the urinary bladder. A 46-year-old man presented with gross hematuria and increased serum concentrations of both carbohydrate antigen (CA) 19-9 and beta-human chorionic gonadotropin (beta-hCG). The tumor was composed of conventional urothelial carcinoma and plasmacytoid variant, both positive for epithelial markers. In addition, plasmacytoid tumor cells were positive for an accepted marker of plasma cell origin, CD138. CA19-9 was mainly expressed in conventional urothelial carcinoma cells, and beta-hCG was mainly produced by plasmacytoid tumor cells. This is the first report, to our knowledge, indicating beta-hCG can be produced by plasmacytoid bladder cancer cells lacking trophoblastic features.

摘要

浆细胞样尿路上皮癌是膀胱中一种罕见的恶性肿瘤。一名46岁男性出现肉眼血尿,血清中糖类抗原(CA)19-9和β-人绒毛膜促性腺激素(β-hCG)浓度均升高。肿瘤由传统尿路上皮癌和浆细胞样变体组成,两者上皮标志物均呈阳性。此外,浆细胞样肿瘤细胞对于公认的浆细胞起源标志物CD138呈阳性。CA19-9主要表达于传统尿路上皮癌细胞,β-hCG主要由浆细胞样肿瘤细胞产生。据我们所知,这是第一份表明缺乏滋养层特征的浆细胞样膀胱癌细胞可产生β-hCG的报告。

相似文献

1
Urothelial carcinoma with plasmacytoid variants producing both human chorionic gonadotropin and carbohydrate antigen 19-9.具有产生人绒毛膜促性腺激素和糖类抗原19-9的浆细胞样变体的尿路上皮癌。
Urology. 2006 Oct;68(4):891.e7-10. doi: 10.1016/j.urology.2006.05.029.
2
[Beta-hCG producing urothelial carcinoma of the urinary bladder: a case report].
Hinyokika Kiyo. 2008 Apr;54(4):289-92.
3
[A case of human chorionic gonadotropin-producing bladder cancer].
Hinyokika Kiyo. 2001 Jan;47(1):47-9.
4
Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.膀胱浆细胞样尿路上皮癌:5例的组织学和临床特征
J Urol. 2008 Nov;180(5):1923-7. doi: 10.1016/j.juro.2008.07.035. Epub 2008 Sep 17.
5
Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases.浆细胞样尿路上皮癌:17例形态学详细分析及临床病理相关性研究
Am J Surg Pathol. 2009 Mar;33(3):417-24. doi: 10.1097/PAS.0b013e318186c45e.
6
Plasmacytoid urothelial carcinoma of the bladder.膀胱浆细胞样尿路上皮癌
Hum Pathol. 2009 Jul;40(7):1023-8. doi: 10.1016/j.humpath.2009.01.001. Epub 2009 Mar 17.
7
CD138-positive plasmacytoid urothelial carcinoma of the bladder.膀胱CD138阳性浆细胞样尿路上皮癌
Int J Surg Pathol. 2008 Apr;16(2):215-7. doi: 10.1177/1066896907306847.
8
Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.膀胱浆细胞样移行细胞癌:9例临床病理研究
Am J Surg Pathol. 2008 May;32(5):752-7. doi: 10.1097/PAS.0b013e318159af9e.
9
[Urinary bladder transitional cell carcinoma with trophoblastic differentiation].[伴有滋养层分化的膀胱移行细胞癌]
Harefuah. 1997 Apr 1;132(7):452-4, 528.
10
Sarcomatoid urothelial carcinoma with choriocarcinomatous features: first report of an unusual case.具有绒毛膜癌特征的肉瘤样尿路上皮癌:首例罕见病例报告
Urology. 2007 Oct;70(4):812.e11-4. doi: 10.1016/j.urology.2007.07.050.

引用本文的文献

1
Aberrant trophoblastic differentiation in human cancer: An emerging novel therapeutic target (Review).人类癌症中异常的滋养细胞分化:一个新兴的治疗新靶点(综述)。
Oncol Rep. 2024 Mar;51(3). doi: 10.3892/or.2024.8701. Epub 2024 Jan 19.
2
Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications.浆细胞性尿路上皮癌的分子特征及其对治疗意义的影响。
Cancer Treat Res Commun. 2023;37:100779. doi: 10.1016/j.ctarc.2023.100779. Epub 2023 Nov 17.
3
Plasmacytoid urothelial carcinoma of renal pelvis with positive zinc finger E-box-binding homeobox 1: a case report.
肾盂黏膜浆细胞样尿路上皮癌伴锌指 E 盒结合同源盒 1 阳性:病例报告。
Diagn Pathol. 2020 Oct 8;15(1):124. doi: 10.1186/s13000-020-01043-6.
4
Metastatic Plasmacytoid Bladder Cancer Harboring a CDH-1 Mutation and Producing High Levels of CA 19-9. A Case Report and Literature Review.携带有 CDH-1 突变且产生高水平 CA 19-9 的转移性浆细胞性膀胱癌。病例报告及文献复习。
Am J Case Rep. 2020 Jul 9;21:e923130. doi: 10.12659/AJCR.923130.
5
Bladder Stones Associated with an Aggressive Plasmacytoid Variant of Urothelial Cancer: A Rare Case and Literature Review.与侵袭性浆细胞样变异型尿路上皮癌相关的膀胱结石:1例罕见病例及文献综述
Curr Urol. 2020 Jan;13(4):217-223. doi: 10.1159/000499268. Epub 2020 Jan 7.
6
microRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1.微小RNA-145通过下调syndecan-1促进人尿路上皮癌的分化。
BMC Cancer. 2015 Oct 29;15:818. doi: 10.1186/s12885-015-1846-0.
7
[Not Available].[无可用内容]
Can Urol Assoc J. 2014 Sep;8(9-10):E733-8. doi: 10.5489/cuaj.2017.
8
Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.膀胱浆细胞样尿路上皮癌:一项临床病理研究及文献综述
Int J Clin Exp Pathol. 2012;5(6):601-8. Epub 2012 Jul 29.
9
Plasmacytoid urothelial carcinoma of the bladder: a case report.膀胱浆细胞样尿路上皮癌:一例报告
Cases J. 2009 Apr 28;2:6647. doi: 10.1186/1757-1626-0002-0000006647.
10
Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma.硫酸乙酰肝素蛋白聚糖-1(CD138)在人尿路上皮癌细胞存活中的作用。
Cancer Sci. 2010 Jan;101(1):155-60. doi: 10.1111/j.1349-7006.2009.01379.x. Epub 2009 Oct 6.